Enwave Corporation Stock
Your prediction
Enwave Corporation Stock
Heavy losses for Enwave Corporation today as the stock fell by -€0.009 (-6.670%).
Pros and Cons of Enwave Corporation in the next few years
Pros
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Enwave Corporation vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enwave Corporation | -6.670% | 6.977% | -17.857% | -46.923% | -41.525% | -34.906% | -78.505% |
| Aurinia Pharmaceuticals Inc. | 1.300% | -4.050% | -11.475% | 75.933% | -0.631% | 32.525% | 37.649% |
| Spectral Medical Inc | 2.440% | -4.651% | 0.000% | 64.000% | 3.145% | 290.476% | 230.645% |
| Xenon Pharmaceuticals Inc. | - | 0.000% | 10.476% | 114.815% | 52.632% | 74.699% | - |
News
EnWave Reports 2026 First Quarter Consolidated Interim Financial Results
Vancouver, B.C., February 20th, 2026. EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the first
EnWave Signs Royalty-Bearing License with Bowen Gumlu Grower’s Association of Australia
Vancouver, B.C., February 2nd, 2026, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today announced that the Company has signed a royalty-bearing commercial license